The Impact of Comorbidities, EEG Abnormalities, and ASM Use as a Predicting Outcomes in Pediatric Status Epilepticus

Dongmei Chen1, Qin Zhang1, Hongjun Miao1

  • 1Emergency Department/Intensive Care Unit, Children's Hospital of Nanjing Medical University, Nanjing, 210008, People's Republic of China.

Insights

Pediatric intensive care unit patients with status epilepticus and comorbidities, abnormal EEG, or multiple anti-seizure medications (ASMs) face poor prognosis. Increased ASM use is a key independent risk factor for unfavorable outcomes.

Area of Science:

  • Pediatric Intensive Care
  • Neurology
  • Clinical Prognostics

Background:

  • Pediatric intensive care unit (PICU) patients present with diverse conditions impacting prognosis.
  • Identifying prognostic factors is vital for optimizing treatment and improving outcomes in critically ill children.

Purpose of the Study:

  • To identify risk factors for poor prognosis in pediatric patients with status epilepticus (SE).
  • To evaluate the predictive value of the STEPSS and END-IT scoring systems for SE outcomes.

Main Methods:

  • Retrospective analysis of 203 pediatric patients with SE admitted to the PICU.
  • Categorization into good and poor prognosis groups based on 3-month Glasgow Outcome Scale (GOS) scores.
  • Statistical analysis, including logistic regression and ROC curve analysis for scoring systems.

Main Results:

  • 31.5% of patients experienced a poor prognosis.
  • Comorbidities, abnormal EEG findings, and polypharmacy with anti-seizure medications (ASMs) were significantly associated with poor prognosis.
  • Use of two or more ASMs was an independent risk factor (OR 4.48), while STEPSS and END-IT scores showed limited predictive value.

Conclusions:

  • Comorbidities, abnormal EEG, and increased ASM use are significant risk factors for poor prognosis in pediatric SE.
  • ASM usage critically influences patient outcomes in SE.
  • Further research is needed to refine prognostic models for pediatric SE.
Abstract